查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
掌腱膜挛缩症市场，按类型、疾病类型、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419084

掌腱膜挛缩症市场，按类型、疾病类型、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Dupuytren's Disease Market, By Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年掌腱膜挛缩症市场规模为 41.310 亿美元，2023 年至 2030 年复合CAGR为 4.44%。

掌腱膜挛缩症市场-市场动态

医学研究和技术的不断发展以及疾病的流行推动了市场需求

这种疾病发生率的上升推动了市场的显着扩张。最近发表在《手外科杂誌》上的一项研究表明，越来越多的患者需要治疗选择，并显示诊断病例显着增加。为了满足对高效管理技术的需求，製药公司和医疗器材製造商扩大了研发支出。此外，根据2021年在美国进行的人口调查，高达7%的人出现临床症状，其中超过三分之一的人受到掌腱膜挛缩症的影响。

此外，医学技术和科学发展的不断增长也促进了市场的成长。随着产业的发展，利害关係人有潜力满足患者不断变化的需求并改善疾病管理结果。 《手外科杂誌》强调需要更多的非手术方法来治疗掌腱膜挛缩症，并鼓励手外科医师就新的治疗方法和技术进行持续对话。

掌腱膜挛缩症市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 4.44% 左右的CAGR成长
  • 根据类型细分，由于高度重视开发治疗方案，治疗细分市场预计将在 2022 年显示最大的市场份额。
  • 从疾病类型细分来看，2022年疾病类型细分为主导细分，以掌筋膜为主要特征。
  • 根据最终用户细分，医院细分市场是 2022 年的领先细分市场，主要是由于医疗保健设施的不断发展。
  • 从地区来看，由于掌腱膜挛缩症的高发生率，北美是 2022 年的主要收入来源。

掌腱膜挛缩症市场-細項分析：

全球掌腱膜挛缩症市场根据类型、疾病类型、最终用户和地区进行细分。

市场根据类型分为两类：诊断和治疗。治疗领域占据市场主导地位。製药公司致力于开发治疗疾病的创新治疗解决方案。

根据疾病类型，市场分为三类： I型、II型和III型。 II 类细分市场在市场中占据主导地位，并可能在预测期内保持其主导地位。数位线缆损伤疾病的日益普及可能会促进市场成长。

根据最终用户，市场分为四大类：医院、诊所、研究机构等。医院领域在市场中占据主导地位，并可能在预测期内保持其主导地位。医院提供整体护理治疗，预计将推动市场成长。

掌腱膜挛缩症市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

掌腱膜挛缩症市场-竞争格局：

由于患者数量的增加、治疗的改善和意识的提高，市场正在显着扩大。主要参与者可以透过提供专门的护理和有效的治疗来利用这些机会。为了增加产业份额，市场参与者持续参与合併、收购和合作等策略活动。例如，2022 年 4 月，180 Life Sciences 和牛津大学宣布公布 Dupuytren 的 2b 期研究结果。

最近的发展：

2023 年 4 月，一家新成立的专业製药公司 Ventoux Biosciences 致力于改变包括掌腱膜挛缩症在内的纤维化疾病的治疗。

目录

第一章：掌腱膜挛缩症市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的掌腱膜挛缩症市场片段
    • 依疾病类型分類的掌腱膜挛缩症市场片段
    • 最终用户的掌腱膜挛缩症市场片段
    • 按国家/地区分類的掌腱膜挛缩症市场片段
    • 按地区分類的掌腱膜挛缩症市场片段
  • 竞争洞察

第 3 章：掌腱膜挛缩症主要市场趋势

  • 掌腱膜挛缩症市场驱动因素
    • 市场驱动因素的影响分析
  • 掌腱膜挛缩症市场限制
    • 市场限制影响分析
  • 掌腱膜挛缩症市场机会
  • 掌腱膜挛缩症市场未来趋势

第 4 章：掌腱膜挛缩症产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：掌腱膜挛缩症市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：掌腱膜挛缩症市场格局

  • 掌腱膜挛缩症市场占有率分析，2022 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：掌腱膜挛缩症市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 诊断
    • 治疗

第 8 章：掌腱膜挛缩症市场 - 依疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • Ⅰ型
    • II型
    • Ⅲ型

第 9 章：掌腱膜挛缩症市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 研究机构
    • 其他的

第 10 章：掌腱膜挛缩症市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 掌腱膜挛缩症北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 掌腱膜挛缩症欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 掌腱膜挛缩症亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 掌腱膜挛缩症拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 掌腱膜挛缩症中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：关键供应商分析 - 掌腱膜挛缩症产业

  • 竞争仪表板
  • 公司简介
    • BASF SE
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Endo International plc
    • Bristol-Meyers Squibb Company
    • Spear Pharmaceuticals
    • Fresenius Kabi AG
    • GSK plc
    • AstraZeneca
    • Hikma Pharmaceuticals PLC
    • LEO Pharma A/S
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2149

REPORT HIGHLIGHT

Dupuytren's Disease Market size was valued at USD 4,131.00 Million in 2022, expanding at a CAGR of 4.44% from 2023 to 2030.

Dupuytren's disease causes Fascia, a layer of tissue beneath the skin, thickens abnormally in the palm of your hand near the base of your fingers. This enlarged region could turn into a thick band or hard lump.

Dupuytren's Disease Market- Market Dynamics

Increasing developments in medical research & technology and prevalence of disease to propel market demand

The rising incidence of the illness is fueling the market's notable expansion. A growing number of patients need treatment choices, as evidenced by a recent study that was published in the Journal of Hand Surgery and showed a noticeable increase in diagnosed cases. To address the demand for efficient management techniques, pharmaceutical businesses and makers of medical devices have expanded their spending in research and development. Furthermore, according to a population survey conducted in the United States in 2021, up to 7% of people have clinical symptoms, and over one-third of those people are impacted by Dupuytren's contractures.

Furthermore, the growing number of technological and scientific developments in medicine also contributing to market growth. Stakeholders have potential to address patients' changing requirements and improve illness management results as the industry grows. The Journal of Hand Surgery highlights the need for more nonsurgical methods to treat Dupuytren's disease and encourages continuous dialogue among hand surgeons about new treatments and techniques.

Dupuytren's Disease Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.44% over the forecast period (2023-2030)
  • Based on Type segmentation, treatment segment was predicted to show maximum market share in the year 2022, owing to high focus on developing treatment options.
  • Based on Disease Type segmentation, disease type II segment was the leading segment in 2022, mainly characterized palmer fascia.
  • Based on End-User segmentation, hospitals segment was the leading segment in 2022, mainly due to increasing development healthcare facilities.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to high prevalence of Dupuytren disease.

Dupuytren's Disease Market- Segmentation Analysis:

The Global Dupuytren's Disease Market is segmented on the basis of Type, Disease Type, End-User, and Region.

The market is divided into two categories based on Type: diagnosis and treatment. The treatment segment dominates the market. Pharmaceutical companies are focusing on developing innovative treatment solutions for treatment of disease.

The market is divided into three categories based on Disease Type: Type I, Type II, and Type III. The Type II segment dominates the market and is likely to maintain its dominance during the forecast period. The growing prevalence of disease with digital cords impairment are likely to boost market growth.

The market is divided into four categories based on End-User: hospitals, clinics, research institutes, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. Hospitals provide holistic care treatment care and is expected to boost the market growth.

Dupuytren's Disease Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Dupuytren's Disease Market- Competitive Landscape:

The market is expanding significantly because of rising patient numbers, improved treatment, and more awareness. Major players can take advantage of these opportunities by providing specialized care and efficient therapies. To increase their industry share, market players are constantly taking part in strategic activities including mergers, acquisitions, and partnerships. For example, in April 2022, 180 Life Sciences and the University of Oxford announced the publication of positive Phase 2b study results for Dupuytren's.

Recent Developments:

In April 2023, a newly launched specialty pharmaceutical company called Ventoux Biosciences, which is dedicated to transforming the management of fibrotic diseases, including Dupuytren's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DUPUYTREN'S DISEASE MARKET KEY PLAYERS

  • BASF SE
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Private Limited
  • Endo International plc
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • Fresenius Kabi AG
  • GSK plc
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • LEO Pharma A/S
  • Others

GLOBAL DUPUYTREN'S DISEASE MARKET, BY TYPE

  • Diagnosis
  • Treatment

GLOBAL DUPUYTREN'S DISEASE MARKET, BY DISEASE TYPE

  • Type I
  • Type II
  • Type III

GLOBAL DUPUYTREN'S DISEASE MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

GLOBAL DUPUYTREN'S DISEASE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dupuytren's Disease Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dupuytren's Disease Market Snippet by Type
    • 2.1.2. Dupuytren's Disease Market Snippet by Disease Type
    • 2.1.3. Dupuytren's Disease Market Snippet by End-User
    • 2.1.4. Dupuytren's Disease Market Snippet by Country
    • 2.1.5. Dupuytren's Disease Market Snippet by Region
  • 2.2. Competitive Insights

3. Dupuytren's Disease Key Market Trends

  • 3.1. Dupuytren's Disease Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dupuytren's Disease Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dupuytren's Disease Market Opportunities
  • 3.4. Dupuytren's Disease Market Future Trends

4. Dupuytren's Disease Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dupuytren's Disease Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dupuytren's Disease Market Landscape

  • 6.1. Dupuytren's Disease Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dupuytren's Disease Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Diagnosis
    • 7.1.3. Treatment

8. Dupuytren's Disease Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Type I
    • 8.1.3. Type II
    • 8.1.4. Type III

9. Dupuytren's Disease Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Dupuytren's Disease Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Dupuytren's Disease Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Dupuytren's Disease Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Dupuytren's Disease Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Dupuytren's Disease Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Dupuytren's Disease Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Dupuytren's Disease Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. BASF SE
    • 11.2.2. Bayer AG
    • 11.2.3. Novartis AG
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Nantong Jinghua Pharmaceutical Co., Ltd.
    • 11.2.6. Actiza Pharmaceutical Private Limited
    • 11.2.7. Endo International plc
    • 11.2.8. Bristol-Meyers Squibb Company
    • 11.2.9. Spear Pharmaceuticals
    • 11.2.10. Fresenius Kabi AG
    • 11.2.11. GSK plc
    • 11.2.12. AstraZeneca
    • 11.2.13. Hikma Pharmaceuticals PLC
    • 11.2.14. LEO Pharma A/S
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dupuytren's Disease Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Dupuytren's Disease Market, by Type 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Dupuytren's Disease Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Dupuytren's Disease Market, by End-User 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dupuytren's Disease Market, by Region 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)